Volume 8, Issue 6, Pages 519-529 (June 2009) NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial Per Soelberg Sorensen, MD, Svein Ivar Mellgren, MD, Anders Svenningsson, MD, Irina Elovaara, MD, Jette Lautrup Frederiksen, MD, Antonie Giaever Beiske, MD, Kjell-Morten Myhr, MD, Lise Vejby Søgaard, PhD, Inge Christoffer Olsen, PhD, Magnhild Sandberg- Wollheim, MD The Lancet Neurology Volume 8, Issue 6, Pages 519-529 (June 2009) DOI: 10.1016/S1474-4422(09)70085-7 Copyright © 2009 Elsevier Ltd Terms and Conditions
Figure 1 Trial profile ITT=intention to treat. The Lancet Neurology 2009 8, 519-529DOI: (10.1016/S1474-4422(09)70085-7) Copyright © 2009 Elsevier Ltd Terms and Conditions
Figure 2 Kaplan–Meier plots of time to sustained progression of disability The Lancet Neurology 2009 8, 519-529DOI: (10.1016/S1474-4422(09)70085-7) Copyright © 2009 Elsevier Ltd Terms and Conditions